Alpha1-Proteinase Inhibitor (Human)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Alpha1-Proteinase Inhibitor (Human), covering 2022-03-21 to 2022-03-21. Get the full timeline:
Most recent: Clinical Trial Update: Long-term Safety of Alpha1-Proteinase Inhibitor (Human) in Japanese Subjects With Alpha1 Antitrypsin Deficiency (GTI1401-OLE) [Phase 1, Phase 2]